Ozawade 4,5 mg Film-coated tablets

Ozawade is a prescription medication containing pitolisant, which is used for the treatment of excessive daytime sleepiness associated with obstructive sleep apnea. The brand was developed by Bioprojet, a French pharmaceutical company founded in 1991 by researchers Dr. Jeanne-Marie Lecomte and Prof. Jean-Charles Schwartz. The medication is specifically designed to act on H3 receptors in the brain to increase alertness. Ozawade is primarily manufactured in France, where Bioprojet maintains its core research and production operations. The brand remains under the ultimate ownership of Bioprojet Pharma, which is headquartered in Paris, France. In the German market, the product is distributed through the company's local subsidiary, Bioprojet Deutschland GmbH, which manages the commercialization and clinical supply across Germany.